Procaine-induced contraction in vein and its modification by drugs.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002415:Cats; D003250:Constriction / Q000187:drug effects; D004837:Epinephrine / Q000494:pharmacology; D006584:Hexamethonium Compounds / Q000494:pharmacology; D006885:Hydroxybutyrates / Q000494:pharmacology; D066298:In Vitro Techniques; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D008642:Mesenteric Veins / Q000187:drug effects; D008784:Methysergide / Q000494:pharmacology; D009020:Morphine / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects*; D009130:Muscle, Smooth / Q000187:drug effects*; D009638:Norepinephrine / Q000494:pharmacology; D010042:Ouabain / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D010740:Phospholipases / Q000494:pharmacology; D011343:Procaine / Q000037:antagonists & inhibitors* / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000494:pharmacology
D006584:Hexamethonium Compounds; D006885:Hydroxybutyrates; D010643:Phenoxybenzamine; D012701:Serotonin; D011343:Procaine; D010042:Ouabain; D009020:Morphine; D001285:Atropine; D008238:Lysergic Acid Diethylamide; D011433:Propranolol; D010740:Phospholipases; D000109:Acetylcholine; D009638:Norepinephrine; D008784:Methysergide; D004837:Epinephrine; D010646:Phentolamine